Nephrotoxicity attributed to meglumine antimoniate (Glucantime) in the treatment of generalized cutaneous leishmaniasis

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 41, Issue 1, 1999, Pages 33-37

  Rodrigues, Mirian Lane O ^a   Costa, R S ^b   Souza, C S ^b   Foss, N T ^b   Roselino, A M F ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Antimonials; Leishmaniasis; Nephrotoxicity

Indexed keywords

MEGLUMINE ANTIMONATE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DOSE RESPONSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TUBULE NECROSIS; MALE; NEPHROTOXICITY; SKIN BIOPSY; SKIN DEFECT; SKIN LEISHMANIASIS; URINE OSMOLALITY;

EID: 0032942817     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0036-46651999000100007     Document Type: Article

References (16)

1. ALBERTO, F.L.; CRUZ, A.K.; ALMEIDA, A.M. & ROSELINO, A.M.F. -Leishmania amazonensis no interior do Estado de São Paulo? In: ANAIS DO CONGRESSO BRASILEIRO DE DERMATOLOGIA, 48, Curitiba, 1993. p. 162.
2. BENENSON, A.S. - Leishmaniasis. I. Leishmaniasis cutanea y mucocutanea. In: BENENSON, A.S. El control de las enfermedades transmisibles en el hombre: informe oficial de la Asociación Estadounidense de Salud Pública. 15. ed. Washington, OPS, 1992. p. 322-326.
3. BRASIL. MINISTÉRIO DA SAÚDE - Leishmaniose tegumentar americana no Brasil. Brasília, 1996.
4. k in the treatment of leishmaniasis. Rev. Inst. Med. trop. S. Paulo, 32: 249-251, 1990.
5. GOMES, A.C. - Eipidemiological profile of cutaneous and mucocutaneous leishmaniasis in Brazil. An. bras. Derm., 67: 55-60, 1992.
6. HARVEY, S.G. - Heavy metals. In: GOODMAN, L.S. & GILMAN, A., ed. The pharmacological basis of therapeutics. 5. ed. New York, MacMillan, 1975. p. 924-945.
7. HERWALDT, B.L. & BERMAN, J.D.-Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Amer. J. trop. Med. Hyg., 46: 296-306, 1992.
8. JOLLIFFE, D.S. - Nephrotoxicity of pentavalent antimonials. Lancet, 9: 584, 1985.
9. KOFF, A.B. & ROSEN, T. - Treatment of cutaneous leishmaniasis. J. Amer. Acad. Derm., 31: 693-708, 1994.
10. LAINSON, R. & SHAW, J.J. - Epidemiology and ecology of leishmaniasis in Latin-America. Nature (Lond.), 273: 595-600, 1978.
11. MELBY. P.C.; KREUTZER, R.D.; MCMAHON-PRATT, D; GAM, A.A. & NEVA, F.A. - Cutaneous leishmaniasis: review of 59 cases seen at the National Institutes of Health. Clin. Infect. Dis., 15: 924-937, 1992.
12. REES, P.M.; KEATING, M.I.; KAGER, P.A. & HOKMEYER, W.T. - Renal clearance of pentavalent antimony (sodium stibogluconate). Lancet, 2: 226-229, 1980.
13. SAMPAIO, R.N.R.; ROCHA, R.A.A.; MARSDEN, P.D. et al. - American cutaneous leishmaniasis. Casuistry in the School Hospital of University of Brasília. An. bras. Derm., 55: 69-76, 1980.
14. VEIGA, J.P.R.; ROSA, T.T.; KIMACHI, T. et al. - Renal function in patients with inucocutaneous leishmaniasis treated with pentavalent antimonials. Rev. Inst. Med. trop. S. Paulo, 27: 298-302, 1985.
15. VEIGA, J.P.R.; WOLFF, E.R.; SAMPAIO, R.N. & MARSDEN, P.D. - Renal tubular dysfunction in patients with mucocutaneous leishmaniasis treated with pentavalent antimonials. Lancet, 3: 569, 1983.
16. WANKE, N.C.F.; BIRKENHAUER, M.C.; MACEIRA, J.M.P.; SILVA. F.C. & PEREZ, M. - American tegumentary leishmaniasis. Retrospective study of 65 cases. An. bras. Derm., 66: 49-54, 1991.